Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 07 2024
0mins
Source: Globenewswire
Candel Therapeutics Presentation: Candel Therapeutics, a biopharmaceutical company focused on cancer immunotherapies, will have its CEO Paul Peter Tak present at the Jefferies London Healthcare Conference on November 20, 2024.
Company Overview and Product Development: Candel is developing multimodal biological immunotherapies, with lead candidates CAN-2409 and CAN-3110 currently in various clinical trials targeting non-small cell lung cancer, pancreatic cancer, prostate cancer, and recurrent high-grade glioma.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
